BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Barth H. Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade. World J Hepatol 2015; 7(5): 725-737 [PMID: 25914773 DOI: 10.4254/wjh.v7.i5.725]
URL: https://www.wjgnet.com/1948-5182/full/v7/i5/725.htm
Number Citing Articles
1
Urbano Sbarigia, Daniel Wirth, Karen Van Nuys, Caroline Huber, Ron Brookmeyer, Jona Stahmeyer, Christian Krauth. Economic study of the value of expanding HCV treatment capacity in GermanyBMJ Open Gastroenterology 2017; 4(1): e000130 doi: 10.1136/bmjgast-2016-000130
2
Mohammad Enamul Hoque Kayesh, Sayeh Ezzikouri, Takahiro Sanada, Haiying Chi, Yukiko Hayashi, Khadija Rebbani, Bouchra Kitab, Aya Matsuu, Noriaki Miyoshi, Tsunekazu Hishima, Michinori Kohara, Kyoko Tsukiyama-Kohara. Oxidative Stress and Immune Responses During Hepatitis C Virus Infection in Tupaia belangeriScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10329-7
3
Ewelina Krol, Gabriela Pastuch-Gawolek, Binay Chaubey, Gabriela Brzuska, Karol Erfurt, Boguslaw Szewczyk. Novel Uridine Glycoconjugates, Derivatives of 4-Aminophenyl 1-Thioglycosides, as Potential Antiviral CompoundsMolecules 2018; 23(6): 1435 doi: 10.3390/molecules23061435
4
Timothy T. Spear, Timothy P. Riley, Gretchen E. Lyons, Glenda G. Callender, Jeffrey J. Roszkowski, Yuan Wang, Patricia E. Simms, Gina M. Scurti, Kendra C. Foley, David C. Murray, Lance M. Hellman, Rachel H. McMahan, Makio Iwashima, Elizabeth Garrett-Mayer, Hugo R. Rosen, Brian M. Baker, Michael I. Nishimura. Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityJournal of Leukocyte Biology 2016; 100(3): 545 doi: 10.1189/jlb.2A1215-561R
5
José M. Benito, Javier García-Samaniego, Marcial García, Antonio Madejón, Luz Martín-Carbonero, Alfonso Cabello, Beatriz Álvarez, Miguel Górgolas, Norma Rallón. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis CJournal of Interferon & Cytokine Research 2017; 37(6): 278 doi: 10.1089/jir.2016.0078
6
Ascensión Ariza-Mateos, Rosa Díaz-Toledano, Timothy M. Block, Samuel Prieto-Vega, Alex Birk, Jordi Gómez. Geneticin Stabilizes the Open Conformation of the 5′ Region of Hepatitis C Virus RNA and Inhibits Viral ReplicationAntimicrobial Agents and Chemotherapy 2016; 60(2): 925 doi: 10.1128/AAC.02511-15
7
John D. Groopman. Hepatocellular Carcinoma2016; : 25 doi: 10.1007/978-3-319-34214-6_2
8
Pier Angelo Tovo, Stefania Bezzio, Clara Gabiano. Neonatology2018; : 1681 doi: 10.1007/978-3-319-29489-6_251
9
Pier-Angelo Tovo, Carmelina Calitri, Carlo Scolfaro, Clara Gabiano, Silvia Garazzino. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progressionWorld Journal of Gastroenterology 2016; 22(4): 1382-1392 doi: 10.3748/wjg.v22.i4.1382
10
Jacqueline D. Reeves, Neil T. Parkin. Antimicrobial Drug Resistance2017; : 1389 doi: 10.1007/978-3-319-47266-9_35
11
Ozge Cevik, Dan Li, Erdene Baljinnyam, Dinesh Manvar, Erica M. Pimenta, Gulam Waris, Betsy J. Barnes, Neerja Kaushik-Basu. Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinomaJournal of Biological Chemistry 2017; 292(52): 21676 doi: 10.1074/jbc.M117.792721
12
Ahmed Lasfar, Andrew Zloza, Karine A. Cohen-Solal. IFN-lambda therapy: current status and future perspectivesDrug Discovery Today 2016; 21(1): 167 doi: 10.1016/j.drudis.2015.10.021
13
Keanan McGonigle, Tess Carley, Clarissa Hoff. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban PopulationJournal of Racial and Ethnic Health Disparities 2018; 5(5): 1052 doi: 10.1007/s40615-017-0453-y
14
Jacqueline Farinha Shimizu, Caroline Sprengel Lima, Carina Machado Pereira, Cintia Bittar, Mariana Nogueira Batista, Ana Carolina Nazaré, Carlos Roberto Polaquini, Carsten Zothner, Mark Harris, Paula Rahal, Luis Octávio Regasini, Ana Carolina Gomes Jardim. Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus EntryScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16336-y
15
Yu-Ming Lee, Yulander Duh, Shih-Ting Wang, Michael M.C. Lai, Hanna S. Yuan, Carmay Lim. Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A ProteinJournal of the American Chemical Society 2016; 138(11): 3856 doi: 10.1021/jacs.6b00299
16
Erofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, Vasileios Siozos, Vassilios Myrianthopoulos, Emmanuel Mikros, Martin C. Taylor, John M. Kelly, Niki Vassilaki, Grigoris Zoidis. Scaffold hybridization strategy towards potent hydroxamate-based inhibitors ofFlaviviridaeviruses andTrypanosomaspeciesMedChemComm 2019; 10(6): 991 doi: 10.1039/C9MD00200F
17
Hanan H. Rizk, Nadia M. Hamdy, Nadia L. Al-Ansari, Hala O. El-Mesallamy, Ming-Lung Yu. Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4PLOS ONE 2016; 11(4): e0153895 doi: 10.1371/journal.pone.0153895
18
Ewelina Krol, Ilona Wandzik, Gabriela Pastuch-Gawolek, Boguslaw Szewczyk. Anti-Hepatitis C Virus Activity of Uridine Derivatives of 2-Deoxy SugarsMolecules 2018; 23(7): 1547 doi: 10.3390/molecules23071547
19
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
20
Parisa Shiri Aghbash, Nima Hemmat, Javid Sadri Nahand, Ali Shamekh, Mohammad Yousef Memar, Abouzar Babaei, Hossein Bannazadeh Baghi. The role of Th17 cells in viral infectionsInternational Immunopharmacology 2021; 91: 107331 doi: 10.1016/j.intimp.2020.107331
21
Lize Cuypers, Guangdi Li, Pieter Libin, Supinya Piampongsant, Anne-Mieke Vandamme, Kristof Theys. Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug ResistanceViruses 2015; 7(9): 5018 doi: 10.3390/v7092857
22
J.D. Groopman. Comprehensive Toxicology2018; : 188 doi: 10.1016/B978-0-12-801238-3.64104-1
23
Milena S. Cabral, Taciana P.S. Santos, Priscila L. Santos, Maria Isabel Schinoni, Isabela S. Oliveira, Ariana B. Pereira, Ajax M. Atta, Maria Luiza B. Sousa-Atta. Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infectionCytokine 2018; 102: 200 doi: 10.1016/j.cyto.2017.09.015
24
Nikolaos Lougiakis, Efseveia Frakolaki, Panagiota Karmou, Nicole Pouli, Panagiotis Marakos, Vanesa Madan, Ralf Bartenschlager, Niki Vassilaki. Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanismChemical Biology & Drug Design 2017; 90(3): 352 doi: 10.1111/cbdd.12966
25
Pier-Angelo Tovo, Stefania Bezzio, Clara Gabiano. Neonatology2017; : 1 doi: 10.1007/978-3-319-18159-2_251-1
26
Shunhua Guo, Meghan E Kapp, Diego M Beltran, Cesar Y Cardona, Dawn J Caster, Ronald R Reichel, Agnes B Fogo. Spectrum of Kidney Diseases in Patients With Hepatitis C Virus InfectionAmerican Journal of Clinical Pathology 2021; 156(3): 399 doi: 10.1093/ajcp/aqaa238
27
Neerja Kaushik-Basu, Nina K. Ratmanova, Dinesh Manvar, Dmitry S. Belov, Ozge Cevik, Amartya Basu, Mark M. Yerukhimovich, Evgeny R. Lukyanenko, Ivan A. Andreev, Grigory M. Belov, Giuseppe Manfroni, Violetta Cecchetti, David N. Frick, Alexander V. Kurkin, Andrea Altieri, Maria Letizia Barreca. Bicyclic octahydrocyclohepta[ b ]pyrrol-4(1 H )one derivatives as novel selective anti-hepatitis C virus agentsEuropean Journal of Medicinal Chemistry 2016; 122: 319 doi: 10.1016/j.ejmech.2016.06.041
28
Weifeng Gong, Xiaobo Guo, Yangmin Zhang. Depletion of MicroRNA-373 Represses the Replication of Hepatitis C Virus via Activation of Type 1 Interferon Response by Targeting IRF5Yonsei Medical Journal 2018; 59(10): 1181 doi: 10.3349/ymj.2018.59.10.1181
29
Celia Perales, Josep Quer, Josep Gregori, Juan Esteban, Esteban Domingo. Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical ImplicationsViruses 2015; 7(11): 5746 doi: 10.3390/v7112902
30
A. Stubbs, P. Naylor, K. Ravindran, S. Benjaram, N. Reddy, S. Mutchnick, E. May, M. Ehrinpreis, M. Mutchnick. Racial diversity in mortality and morbidity in urban patients with hepatitis CJournal of Viral Hepatitis 2016; 23(6): 439 doi: 10.1111/jvh.12504
31
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in IranWorld Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
32
Hazel Tapp, Thomas Ludden, Lindsay Shade, Jeremy Thomas, Sveta Mohanan, Michael Leonard. Electronic medical record alert activation increase hepatitis C and HIV screening rates in primary care practices within a large healthcare systemPreventive Medicine Reports 2020; 17: 101036 doi: 10.1016/j.pmedr.2019.101036
33
Ikram Sghaier, Etienne Brochot, Besma Y. Loueslati, Wassim Y. Almawi. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysisReviews in Medical Virology 2019; 29(2): e2033 doi: 10.1002/rmv.2033
34
John D Groopman. Environmental health in the biology century: Transitions from population to personalized preventionExperimental Biology and Medicine 2019; 244(9): 728 doi: 10.1177/1535370219837903
35
Ikram Sghaier, Leila Mouelhi, Ezzedine Ghazoueni, Etienne Brochot, Wassim Y. Almawi, Besma Yacoubi-Loueslati. Role of TLRs and IL-6 in the outcome of chronic hepatitis C treatment in Tunisian populationCytokine 2017; 99: 297 doi: 10.1016/j.cyto.2017.08.010
36
Maria C Sorbo, Luca Carioti, Maria C Bellocchi, FrancescoPaolo Antonucci, Daniele Sforza, Ilaria Lenci, Matteo Ciancio Manuelli, Daniele Armenia, Francesco De Leonardis, Martina Milana, Tommaso M Manzia, Mario Angelico, Giuseppe Tisone, Valeria Cento, Carlo F Perno, Francesca Ceccherini‐Silberstein. HCV resistance compartmentalization within tumoral and non‐tumoral liver in transplanted patients with hepatocellular carcinomaLiver International 2019; 39(10): 1986 doi: 10.1111/liv.14168